Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: A report from the Children's Oncology Group

Elizabeth A. Raetz; Mignon L. Loh; Meenakshi Devidas; Kelly Maloney; Leonard A. Mattano; Eric Larsen; Andrew Carroll; Nyla A. Heerema; Julie M. Gastier-Foster; Brent Wood; Michael J. Borowitz; Naomi Winick; Stephen P. Hunger; William L. Carroll

doi:10.3324/haematol.2018.215616

Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: A report from the Children's Oncology Group

Elizabeth A. Raetz, Mignon L. Loh, Meenakshi Devidas, Kelly Maloney, Leonard A. Mattano, Eric Larsen, Andrew Carroll, Nyla A. Heerema, Julie M. Gastier-Foster, Brent Wood, Michael J. Borowitz, Naomi Winick, Stephen P. Hunger, William L. Carroll

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English
Pages (from-to)	E517-E520
Journal	Haematologica
Volume	104
Issue number	11
DOIs	https://doi.org/10.3324/haematol.2018.215616
State	Published - 2019
Externally published	Yes

Access to Document

10.3324/haematol.2018.215616

Cite this

Raetz, E. A., Loh, M. L., Devidas, M., Maloney, K., Mattano, L. A., Larsen, E., Carroll, A., Heerema, N. A., Gastier-Foster, J. M., Wood, B., Borowitz, M. J., Winick, N., Hunger, S. P., & Carroll, W. L. (2019). Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: A report from the Children's Oncology Group. Haematologica, 104(11), E517-E520. https://doi.org/10.3324/haematol.2018.215616

@article{60d992ffb6b140248fe973ebb34dab6f,

title = "Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: A report from the Children's Oncology Group",

author = "Raetz, {Elizabeth A.} and Loh, {Mignon L.} and Meenakshi Devidas and Kelly Maloney and Mattano, {Leonard A.} and Eric Larsen and Andrew Carroll and Heerema, {Nyla A.} and Gastier-Foster, {Julie M.} and Brent Wood and Borowitz, {Michael J.} and Naomi Winick and Hunger, {Stephen P.} and Carroll, {William L.}",

note = "Funding Information: Funding: this work was supported in part by Children{\textquoteright}s Oncology Group grants U10 CA98543, U10 CA98413, U10 CA180886, and U10 CA180899 as well as St. Baldrick{\textquoteright}s Foundation. Funding Information: 1Department of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, NY; 2Department of Pediatrics, Benioff Children{\textquoteright}s Hospital, and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA; 3Department of Biostatistics, Colleges of Medicine, Public Health and Health Professions, University of Florida, Gainesville, FL; 4Department of Pediatrics University of Colorado School of Medicine and Children{\textquoteright}s Hospital Colorado, Aurora, CO; 5HARP Pharma Consulting, Mystic, CT; 6Department of Pediatrics, Maine Children{\textquoteright}s Cancer Program, Scarborough, ME; 7Department of Genetics, University of Alabama at Birmingham, Birmingham, AL; 8Department of Pathology, Wexner Medical Center, Ohio State University, Columbus, OH; 9Institute for Genomic Medicine, Nationwide Children{\textquoteright}s Hospital and Departments of Pathology and Pediatrics, Ohio State University College of Medicine, Columbus, OH; 10Departments of Pathology and Medicine, University of Washington, Seattle, WA;11Departments of Pathology and Oncology, Johns Hopkins Medical Institutions, Baltimore, MD; 12Departments of Pediatrics, UT Southwestern, Dallas, TX and 13Department of Pediatrics and the Center for Childhood Cancer Research, Children{\textquoteright}s Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, PA, USA Acknowledgments: EAR is a KiDS of NYU Foundation Professor of Pediatrics. MLL is a Benioff Chair of Children{\textquoteright}s Health and the Deborah and Arthur Ablin Endowed Chair of Pediatric Molecular Oncology. SPH is the Jeffrey E. Perelman Distinguished Chair in the Department of Pediatrics at The Children's Hospital of Philadelphia.",

year = "2019",

doi = "10.3324/haematol.2018.215616",

language = "English",

volume = "104",

pages = "E517--E520",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "11",

}

Raetz, EA, Loh, ML, Devidas, M, Maloney, K, Mattano, LA, Larsen, E, Carroll, A, Heerema, NA, Gastier-Foster, JM, Wood, B, Borowitz, MJ, Winick, N, Hunger, SP & Carroll, WL 2019, 'Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: A report from the Children's Oncology Group', Haematologica, vol. 104, no. 11, pp. E517-E520. https://doi.org/10.3324/haematol.2018.215616

TY - JOUR

T1 - Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia

T2 - A report from the Children's Oncology Group

AU - Raetz, Elizabeth A.

AU - Loh, Mignon L.

AU - Devidas, Meenakshi

AU - Maloney, Kelly

AU - Mattano, Leonard A.

AU - Larsen, Eric

AU - Carroll, Andrew

AU - Heerema, Nyla A.

AU - Gastier-Foster, Julie M.

AU - Wood, Brent

AU - Borowitz, Michael J.

AU - Winick, Naomi

AU - Hunger, Stephen P.

AU - Carroll, William L.

N1 - Funding Information: Funding: this work was supported in part by Children’s Oncology Group grants U10 CA98543, U10 CA98413, U10 CA180886, and U10 CA180899 as well as St. Baldrick’s Foundation. Funding Information: 1Department of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, NY; 2Department of Pediatrics, Benioff Children’s Hospital, and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA; 3Department of Biostatistics, Colleges of Medicine, Public Health and Health Professions, University of Florida, Gainesville, FL; 4Department of Pediatrics University of Colorado School of Medicine and Children’s Hospital Colorado, Aurora, CO; 5HARP Pharma Consulting, Mystic, CT; 6Department of Pediatrics, Maine Children’s Cancer Program, Scarborough, ME; 7Department of Genetics, University of Alabama at Birmingham, Birmingham, AL; 8Department of Pathology, Wexner Medical Center, Ohio State University, Columbus, OH; 9Institute for Genomic Medicine, Nationwide Children’s Hospital and Departments of Pathology and Pediatrics, Ohio State University College of Medicine, Columbus, OH; 10Departments of Pathology and Medicine, University of Washington, Seattle, WA;11Departments of Pathology and Oncology, Johns Hopkins Medical Institutions, Baltimore, MD; 12Departments of Pediatrics, UT Southwestern, Dallas, TX and 13Department of Pediatrics and the Center for Childhood Cancer Research, Children’s Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, PA, USA Acknowledgments: EAR is a KiDS of NYU Foundation Professor of Pediatrics. MLL is a Benioff Chair of Children’s Health and the Deborah and Arthur Ablin Endowed Chair of Pediatric Molecular Oncology. SPH is the Jeffrey E. Perelman Distinguished Chair in the Department of Pediatrics at The Children's Hospital of Philadelphia.

PY - 2019

Y1 - 2019

UR - http://www.scopus.com/inward/record.url?scp=85074305961&partnerID=8YFLogxK

U2 - 10.3324/haematol.2018.215616

DO - 10.3324/haematol.2018.215616

M3 - Letter

C2 - 31004024

AN - SCOPUS:85074305961

SN - 0390-6078

VL - 104

SP - E517-E520

JO - Haematologica

JF - Haematologica

IS - 11

ER -